The most in-depth section in this issue, our oncology topic covers various areas of the oncology sphere from AI to prostate cancer. Biomap considers the use of AI in immuno-oncology and how it can improve drug discovery (
page 22), KAUST considers the future of targeted oncology drug design and how nuclear magnetic resonance can be used for cancer treatment (
page 25) and Parexel assesses the need for diversity in oncology clinical trials specifically for personalised medicines (
page 28).